CDKN2A and neoplasm: The hYSK1-mediated loss or downregulation of p16INK4a has been shown to result in an increase in the expression of MMP-2 through transcriptional activation of SP-1, and in the enhancement of the migration and invasion of tumor cells including those of the melanoma and fibrosarcoma [7].